Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 28,000 CAMP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Camp4 Therapeutics Corp (CAMP) | Grant/Award | 28,000 | n/a |
| Jun 8, 2026 | Climb Bio, Inc. (CLYM) | Grant/Award | 40,000 | n/a |
| Jun 5, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 40,000 | n/a |
| Apr 1, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 78,873 | n/a |
| Mar 19, 2025 | Camp4 Therapeutics Corp (CAMP) | Grant/Award | 17,787 | n/a |
| Nov 12, 2024 | Climb Bio, Inc. (CLYM) | Grant/Award | 20,000 | n/a |
| Mar 8, 2024 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 67,083 | n/a |
| Nov 3, 2023 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 10,000 | n/a |
| Apr 11, 2023 | Sana Biotechnology, Inc. (SANA) | Grant/Award | 1,100,000 | n/a |
| May 19, 2021 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 1,750 | n/a |